Search

Author/Creator Witek, Barbara

1. ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation. (7th January 2021)

Authors:
Borenäs, Marcus; Umapathy, Ganesh; Lai, Wei‐Yun; Lind, Dan E; Witek, Barbara; Guan, Jikui; Mendoza‐Garcia, Patricia; Masudi, Tafheem; Claeys, Arne; Chuang, Tzu‐Po; El Wakil, Abeer; Arefin, Badrul; Fransson, Susanne; Koster, Jan; Johansson, Mathias; Gaarder, Jennie; Van den Eynden, Jimmy; Hallberg...
Journal:
EMBO journal
Issue:
Volume 40:Number 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells. (22nd August 2013)

Authors:
Sattu, Kamaraj; Hochgräfe, Falko; Wu, Jianmin; Umapathy, Ganesh; Schönherr, Christina; Ruuth, Kristina; Chand, Damini; Witek, Barbara; Fuchs, James; Li, Pui‐Kai; Hugosson, Fredrik; Daly, Roger J.; Palmer, Ruth H.; Hallberg, Bengt
Journal:
FEBS journal
Issue:
Volume 280:Number 21(2013)
Page Start:
5269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search